Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-063956
Filing Date
2011-11-14
Accepted
2011-11-14 13:23:30
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v238396_10q.htm 10-Q 746179
2 EXHIBIT 31 v238396_ex31.htm EX-31 9966
3 EXHIBIT 32 v238396_ex32.htm EX-32 7077
  Complete submission text file 0001144204-11-063956.txt   2316484

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT iccc-20110930.xml EX-101.INS 257200
5 XBRL TAXONOMY EXTENSION SCHEMA iccc-20110930.xsd EX-101.SCH 12787
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iccc-20110930_cal.xml EX-101.CAL 28491
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20110930_def.xml EX-101.DEF 61455
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20110930_lab.xml EX-101.LAB 143278
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20110930_pre.xml EX-101.PRE 85278
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 111200382
SIC: 2835 In Vitro & In Vivo Diagnostic Substances